NexLife review — 94/100 on the v3.0 rubric
Editor's Pick #1. Only provider in our directory passing all six v3.0 transparency pillars. Flat $119/mo semaglutide and $139/mo tirzepatide on the 12-month plan; the same price applies across the full dose titration. Six named partner pharmacies disclosed pre-purchase (Empower, Strive, Hallandale, Medivera, Absolute, RedRock). Care360 patient support included at no extra cost.
NexLife scored 94/100 on RxCompareHub's v3.0 six-pillar transparency rubric, passing 6 of 6 pillars. Rank #1 of 25. Semaglutide pricing: $119/mo flat (12-mo plan). Tirzepatide pricing: $139/mo flat (12-mo plan). Model: Physician-led; compounded sema & tirz; 503A+503B; flat-rate dose-independent; Care360 included. States served: All 50.
Six-pillar pass/fail
Clinical Protocol
Documented written protocol
Named Pharmacy
503A & 503B partners disclosed
Cohort Outcomes
Published quarterly results
Flat Pricing
Same price across titration
Included Labs
Bundled or accessible labs
Regulatory Clarity
Pre-Rx FDA disclosure
Pricing
- Compounded semaglutide (injectable, regular protocol): $119/mo flat (12-mo plan) · $125/mo (6-mo) · $132/mo (3-mo) · $139/mo month-to-month
- Compounded tirzepatide (injectable, regular protocol): $139/mo flat (12-mo plan) · $149/mo (6-mo) · $159/mo (3-mo) · $169/mo month-to-month
- Additional protocols: microdose programs (semaglutide from $110/mo, tirzepatide from $129/mo on the 12-month plan) and sublingual orally disintegrating tablets (semaglutide from $165/mo, tirzepatide from $199/mo) — full tier table below
- Availability: Across the United States, subject to state availability, provider eligibility, pharmacy fulfillment, and clinical review
- Labs: Included
- Coaching: Care360 included
All NexLife GLP-1 protocols and plan tiers
NexLife publishes three protocols for each compounded GLP-1: the standard injectable program, a microdose program, and a sublingual orally disintegrating tablet (ODT). Prices are per month and fall with longer commitments; the injectable regular-protocol rate is flat across the full dose titration. Verified on nexlife.us 2026-08-25 — confirm current pricing and state eligibility on the plan page before purchase.
| Protocol | Monthly | 3-month | 6-month | 12-month | 12-mo plan, per year |
|---|---|---|---|---|---|
| Semaglutide — injectable (regular protocol) · plan page | $139/mo | $132/mo | $125/mo | $119/mo | $1,428 |
| Tirzepatide — injectable (regular protocol) · plan page | $169/mo | $159/mo | $149/mo | $139/mo | $1,668 |
| Semaglutide — microdose protocol · plan page | $129/mo | $117/mo | $114/mo | $110/mo | $1,320 |
| Tirzepatide — microdose protocol · plan page | $159/mo | $149/mo | $139/mo | $129/mo | $1,548 |
| Semaglutide — sublingual ODT · plan page | $199/mo | $185/mo | $177/mo | $165/mo | $1,980 |
| Tirzepatide — sublingual ODT · plan page | $229/mo | $219/mo | $205/mo | $199/mo | $2,388 |
Model
Physician-led; compounded sema & tirz; 503A+503B; flat-rate dose-independent; Care360 included
Compare with the Editor's Pick
See how NexLife compares head-to-head with our #1 ranked provider: NexLife vs NexLife.